Tamoxifen citrate: a glimmer of hope for silicosis

Yoldas O., Karaca T., BİLGİN B. Ç. , Yilmaz O. H. , Simsek G. G. , Alici I. O. , ...Daha Fazla

JOURNAL OF SURGICAL RESEARCH, cilt.193, sa.1, ss.429-434, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 193 Konu: 1
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.jss.2014.08.013
  • Sayfa Sayıları: ss.429-434


Background: Inhalation of crystalline silica nanoparticles causes pulmonary damage resulting in progressive lung fibrosis. Currently, there is no effective treatment for silicosis. Tamoxifen citrate is a selective estrogen receptor modulator, which is one of the adjuvant treatment choices for breast cancer. It is also known with its inhibitory effect on the production of transforming growth factor-beta (TGF-beta) and studied for the anti-fibrotic effect in some fibrotic diseases. The aim of the study was to determine the effect of tamoxifen citrate on the prevention of pulmonary fibrosis and the treatment of silicosis.